XML 47 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Stock Option Plan Activity and Stock Options Granted
The following tables summarize the details of options granted under our stock option plans that were still outstanding as of December 31, 2024, and the assumptions used to value those grants. All such grants were effective at the close of business on the date of grant.
Options
Granted		Option Exercise
Price		Closing Stock
Price on Date
of Grant		December 31, 2024
Date of GrantOptions
Outstanding		Options
Exercisable
January 2, 2024814,912 $64.00 $63.550 766,463 47,567 
January 3, 20231,071,943 $48.00 $47.400 883,852 180,820 
January 3, 2022713,438 $62.00 $61.980 529,511 197,013 
January 4, 2021741,510 $48.00 $47.650 477,333 223,592 
January 2, 2020902,263 $38.00 $37.230 514,889 313,822 
January 2, 20191,316,924 $26.00 $25.705 532,075 404,203 
January 2, 20181,087,936 $27.50 $27.270 318,598 248,436 
January 3, 20171,529,578 $23.50 $23.475 158,168 117,840 
April 19, 20161,690,880 $23.00 $22.870 47,038 47,038 
Total9,869,384 4,227,927 1,780,331 
A summary of activities under our stock option plans consisted of the following:
Options
Outstanding
Exercise
Price (1)
Remaining
Life (2)
Outstanding as of January 1, 20244,974,078 $38.70 5.99
Granted814,912 $64.00 9.00
Exercised(1,338,085)$29.72 
Cancelled/forfeited(222,978)$48.12 
Outstanding as of December 31, 20244,227,927 $45.93 6.28
Exercisable as of December 31, 20241,780,331 $38.08 4.94
 
Options
Outstanding
Exercise
Price (1)
Remaining
Life (2)
Outstanding as of January 1, 20235,374,736 $34.37 5.66
Granted1,071,943 $48.00 9.00
Exercised(1,170,693)$25.69 
Cancelled/forfeited(301,908)$45.00 
Outstanding as of December 31, 20234,974,078 $38.70 5.99
Exercisable as of December 31, 20232,197,022 $30.88 4.54
(1) Weighted average exercise price.
(2) Weighted average remaining contractual life in years.
Fair Value Assumptions for Options Granted
Date of GrantRisk-free
Interest Rate		Expected Life
of Option in
Years		Expected
Dividend
Yield		Expected
Stock
Volatility		Estimated Fair
Value of Stock
Option
January 2, 20243.8% 5.002.2% 28.44 %$15.87 
January 3, 20234.0% 5.002.6% 29.58 %$11.62 
January 3, 20221.3% 5.001.7% 28.52 %$13.68 
January 4, 20210.4% 5.002.0% 29.17 %$9.57 
January 2, 20201.7% 5.002.4% 25.70 %$6.81 
January 2, 20192.5% 5.002.9% 23.96 %$4.40 
January 2, 20182.2% 5.002.3% 23.45 %$5.02 
January 3, 20171.9% 5.002.6% 24.49 %$4.20 
April 19, 20161.3% 5.002.6% 26.34 %$4.09 
Schedule of Common Stock Outstanding Roll Forward
Shares of common stock outstanding were as follows:
202420232022
Balance at beginning of year571,982,367 570,811,674 575,464,682 
Stock options exercised1,338,085 1,170,693 346,992 
Purchases of common stock— — (5,000,000)
Balance at end of year573,320,452 571,982,367 570,811,674 
Reconciliation of Denominators Used in Computation of Basic and Diluted Net Income Per Share
The following tables present a reconciliation of the denominators used in the computation of basic and diluted net income per share and a summary of the options to purchase shares of common stock which were excluded from the diluted net income per share calculation because they were anti-dilutive:
Reconciliation202420232022
Basic weighted average shares outstanding572,708,065 571,271,846 573,777,790 
Weighted shares assumed upon exercise of stock options1,574,146 1,736,762 1,845,324 
Diluted weighted average shares outstanding574,282,211 573,008,608 575,623,114 
Anti-Dilutive Options Excluded
Summary of Anti-dilutive Options Excluded202420232022
Options to purchase shares of common stock913,296 1,568,460 1,335,898 
Weighted average exercise prices of options$63.57 53.80 55.25